Etiology of acute myeloid leukemia in the elderly

Seminars in Hematology
David T Bowen

Abstract

The biologic and epidemiologic study of acute myeloid leukaemia (AML) in the elderly is in its infancy. Most epidemiologic data attempting to ascertain the etiology of AML have been obtained from younger cohorts or patients with therapy-related AML. The increasing prevalence of deletional and complex karyotypes in elderly AML patients implies a cumulative genotoxicity over time for this subgroup, given the similar spectrum of abnormalities following exposure to known genotoxic agents such as alkylating chemotherapeutic drugs. Exposure to benzene, radiation, and tobacco smoke are clear but weak risk factors for AML. Polymorphic variants in several genes responsible for genomic protection and integrity are now also weak risk factors for AML. Future epidemiologic studies should correlate exposure data with well-defined biologic subtypes of AML.

References

Dec 1, 1992·International Journal of Epidemiology·S RichardsonI Laffont-Faust
Jul 5, 1992·The New England Journal of Medicine·R E CurtisR N Hoover
Jan 1, 1990·American Journal of Industrial Medicine·R B HayesH Mahar
Aug 1, 1990·JAMA : the Journal of the American Medical Association·Y ShimizuH Kato
Jan 21, 1985·The American Journal of Medicine·M B Urowitz, W D Rider
Jan 1, 1972·British Journal of Industrial Medicine·M AksoyG Dinçol
Nov 1, 1994·International Journal of Cancer. Journal International Du Cancer·H A WeissR Doll
Dec 1, 1993·Environmental Health Perspectives·D J PaustenbachP Price
Jun 1, 1994·Journal of the National Cancer Institute·M L GriemJ H Lubin
Apr 1, 1995·Leukemia & Lymphoma·O CaspiD Ben-Yehuda
Nov 5, 1997·Journal of the National Cancer Institute·L B TravisJ D Boice
Nov 5, 1997·Critical Reviews in Toxicology·P Hotz, R R Lauwerys
Jun 13, 1998·Occupational and Environmental Medicine·N SathiakumarD C Muir
Dec 16, 1998·Occupational and Environmental Medicine·R I NilssonB Järvholm
Sep 4, 1999·Occupational and Environmental Medicine·R ChenA Seaton
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·C F SkibolaG Morgan
Apr 7, 2000·Environmental Health Perspectives·J E KorteE J Duell
Apr 28, 2000·Epidemiology·J BjörkL Hagmar
Nov 22, 2000·Journal of Toxicology and Environmental Health. Part a·L Zeise, T A McDonald
Feb 22, 2001·Science·R D WoodT Lindahl
May 30, 2001·Cancer Genetics and Cytogenetics·A V MoormanG J Morgan
Jul 17, 2001·Cancer Genetics and Cytogenetics·B PoppeF Speleman
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·J M AllanG J Morgan
Mar 6, 2002·Blood·Jens Pedersen-BjergaardClaus Nerlov
May 22, 2002·International Journal of Occupational and Environmental Health·Terri J BallardArduino Verdecchia
Aug 30, 2002·British Journal of Haematology·Ray A CartwrightAnthony V Moorman

❮ Previous
Next ❯

Citations

Jan 1, 2010·American Journal of Epidemiology·Xiaomei MaAmanda J Cross
Jul 24, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G BeadleL Fritschi
Jun 22, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sigurdur Y KristinssonLynn R Goldin
Feb 14, 2012·Chemico-biological Interactions·Joseph Wiemels
Dec 14, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lynn R GoldinMagnus Björkholm
May 5, 2010·Oncology Nursing Forum·Barbara B Rogers
Sep 28, 2020·Journal of Cancer Research and Clinical Oncology·Andrés Cardona-Echeverry, Jeanette Prada-Arismendy

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.